19 earn accreditation in 2015, reflecting steady progress
WASHINGTON, D.C.âThe Association for the Accreditation of Human Research Protection Programs today announced that it has accredited three more research organizations, including two health systems and one academic medical center.
All told, 19 organizations earned AAHRPP accreditation in 2015, including the first historically black college and the first organizations in Europe. AAHRPP continued to make strong inroads across the U.S. and in Asia.
The newly accredited organizations are:
ï· Lancaster General Health, Lancaster, Pennsylvania
ï· Main Line Health, Bryn Mawr, Pennsylvania
ï· University of Massachusetts Worcester, Worcester, Massachusetts
“We are determined to bring the benefits of AAHRPP accreditation to research participants here at home and around the globe,” AAHRPP President and CEO Elyse I. Summers said. “With each accreditation, we take an important step toward realizing the goal of one standard worldwide for research protections.
“We congratulate and applaud all 219 AAHRPP-accredited organizations for their commitment to AAHRPP’s high standards and to high-quality, ethical research.”
AAHRPP-accredited organizations include universities, academic medical centers, community and specialty hospitals, independent institutional review boards, contract research organizations, dedicated research sites, research sponsors, and public health departments.
To earn AAHRPP accreditation, organizations must demonstrate that they have built extensive safeguards into every level of their research operation and that they adhere to high standards for research. In today’s global, collaborative research enterprise, organizations increasingly rely on AAHRPP accreditation status to help identify trusted research partners.
To date, AAHRPP has accredited organizations in 46 states, Belgium, Canada, China, India, Mexico, Republic of Korea, Saudi Arabia, Singapore, Taiwan, and Thailand. All major U.S. independent institutional review boards have earned AAHRPP accreditation. In addition, more 2 than 60 percent of U.S. research-intensive universities and over 65 percent of U.S. medical schools are either AAHRPP accredited or have begun the accreditation process. The National Institutes of Health, the world’s largest public funder of research, has earned accreditation, as has Pfizer, Inc., the largest industry sponsor of clinical research.
About AAHRPP: A nonprofit organization, AAHRPP provides accreditation for organizations that conduct or review human research and can demonstrate that their protections exceed the safeguards required by the U.S. government. To learn more, visit www.aahrpp.org.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.